2019 Maserati Levante S

3.0 L • 6 • 424 hp • 4×4 • AT

ZN661YUA8KX335945

Highlights
Condition
Not provided
Seller
Unknown
Key included
Yes
Docs
Bad
History
1 record
Drive
3.0 L • 6 • 424 hp • 4×4 • AT
Odometer
52,652 mi ≈ 84,735 km
Primary damage
Front end
Secondary damage
Mechanical
Docs
MV907A Parts
Extra
Auction
VIN
ZN661YUA8KX335945
Lot number
83991094
Copart
Sale status
Sold
Location
Buffalo, NY
Description
Fuel type
Gasoline
Body color
White
Body type
SUV
Trim
S
All sales final. Always run reports before bid

Sharing our own experience

Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.

How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides

Popular Maserati models

BiturboCoupeGhibli
GranTurismoGrecaleLevante
MC20Quattroporte

2019 Maserati Levante S • 3.0 L • 6 cyl • 424 hp • 4×4 • Automatic • Copart Lot: 83991094 • VIN: ZN661YUA8KX335945

Find out more about this 2019 Maserati Levante S, available at the Copart salvage car auction as lot 83991094 in Buffalo, NY. This car has Front end main damage. It is listed with Not provided start condition code. Odometer shows 52,652 mi. This White Maserati Levante SUV is equipped with Gasoline 3.0 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for ZN661YUA8KX335945 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.

We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.